Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€18.25

€18.25

1.980%
0.35
1.980%
-
 
19.09.24 / Tradegate WKN: A0STSQ / Name: M1 Kliniken / Stock / Healthcare Providers & Services / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Financial data and news for M1 Kliniken

sharewise wants to provide you with the best news and tools for M1 Kliniken, so we directly link to the best financial data sources.

News

EQS-News: Operating Profit (EBIT) almost doubled: M1 Kliniken AG also grows significantly in the first half of 2024
EQS-News: Operating Profit (EBIT) almost doubled: M1 Kliniken AG also grows significantly in the first half of 2024
EQS-News: Operating Profit (EBIT) almost doubled: M1 Kliniken AG also grows significantly in the first half of 2024
EQS-News: M1 Kliniken AG: Management Board confirms growth targets
EQS-News: M1 Kliniken AG: Management Board confirms growth targets
EQS-News: M1 Kliniken AG: Management Board confirms growth targets
EQS-News: M1 Kliniken announces change in the Management Board and confirms long-term growth strategy
EQS-News: M1 Kliniken announces change in the Management Board and confirms long-term growth strategy
EQS-News: M1 Kliniken announces change in the Management Board and confirms long-term growth strategy
EQS-News: M1 Kliniken AG on a growth path with cutting-edge medicine: EBIT +70% in the first quarter of 2024
EQS-News: M1 Kliniken AG on a growth path with cutting-edge medicine: EBIT +70% in the first quarter of 2024
EQS-News: M1 Kliniken AG on a growth path with cutting-edge medicine: EBIT +70% in the first quarter of 2024
EQS-News: M1 Kliniken AG: Strong profit growth in 2023 underlines ambitious plans for global market leadership in medical aesthetics
EQS-News: M1 Kliniken AG: Strong profit growth in 2023 underlines ambitious plans for global market leadership in medical aesthetics
EQS-News: M1 Kliniken AG: Strong profit growth in 2023 underlines ambitious plans for global market leadership in medical aesthetics
EQS-Adhoc: M1 Kliniken AG: Supervisory Board approves 2023 annual financial statements. Dividend proposal of EUR 0.50 per share
EQS-Adhoc: M1 Kliniken AG: Supervisory Board approves 2023 annual financial statements. Dividend proposal of EUR 0.50 per share
EQS-Adhoc: M1 Kliniken AG: Supervisory Board approves 2023 annual financial statements. Dividend proposal of EUR 0.50 per share
EQS-Adhoc: M1 Kliniken AG decides to start share buyback
EQS-Adhoc: M1 Kliniken AG decides to start share buyback
EQS-Adhoc: M1 Kliniken AG decides to start share buyback
EQS-News: M1 Kliniken AG publishes preliminary figures for financial year 2023:  M1 continues to grow - sales growth of over 10% to € 316,3 million; EBIT increases by 68% to € 15.7 million
EQS-News: M1 Kliniken AG publishes preliminary figures for financial year 2023: M1 continues to grow - sales growth of over 10% to € 316,3 million; EBIT increases by 68% to € 15.7 million
EQS-News: M1 Kliniken AG publishes preliminary figures for financial year 2023: M1 continues to grow - sales growth of over 10% to € 316,3 million; EBIT increases by 68% to € 15.7 million